Skip to main content
. Author manuscript; available in PMC: 2017 Apr 2.
Published in final edited form as: Circ Heart Fail. 2016 Sep;9(9):e002881. doi: 10.1161/CIRCHEARTFAILURE.115.002881

Table 3.

Change in Lipid and Nutritional Variables With LVAD Implantation

Variable At Baseline (±30 d) of LVAD Implantation At 3 mo (±30 d) Post-LVAD Implantation No. of Paired Comparisons Median Change From Baseline to 3 mo P Value for Baseline to 3-mo Comparison
Total cholesterol, mg/dL 125 (101, 151) 150 (125, 179) 129  22 (−3, 64) <0.001
LDL, mg/dL   67 (50, 92)   85 (51,109) 63  12 (−7, 37)   0.01
HDL, mg/dL   32 (25, 39)   42 (35, 50) 67    9 (1, 22) <0.001
Triglycerides, mg/dL   97 (71, 134) 126 (89, 170) 75  28 (−13, 62) <0.001
Albumin, g/dL  3.4 (2.9, 3.8)  4.0 (3.5, 4.3) 286 0.5 (0, 1.0) <0.001

Values expressed as medians (25th, 75th percentile). Baseline-3 mo comparisons made with Wilcoxon matched-pairs signed-rank tests. HDL indicates high-density lipoprotein; LVAD, left ventricular assist device; and LDL, low-density lipoprotein.